Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Healthy Returns

Recent news which mentions Healthy Returns

< Previous 1 2 Next >
Healthy Returns: Trump made sweeping changes to health care in his first week
Tags Biotech and Pharmaceuticals Health & Science Health care industry
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Health & Science Pfizer Inc Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Amazon/com Inc Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags LILLY DRN Merck & Co Inc Health care industry
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Healthy Returns Social issues Novo Nordisk A/S
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Health & Science Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Novo Nordisk A/S Bristol/Myers Squibb Co Health care industry
From CNBC.com News
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
Tags Biotech and Pharmaceuticals Science Health & Science
From CNBC.com News
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Tags Healthy Returns LILLY DRN Social issues
From CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
Tags Healthy Returns Social issues AstraZeneca PLC
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Health & Science Biotech and Pharmaceuticals AstraZeneca PLC
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Novo Nordisk A/S Community Health Systems Inc Health care industry
From CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Novo Nordisk A/S Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags LILLY DRN Healthy Returns Social issues
From CNBC.com News
Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
Tags Biotech and Pharmaceuticals Pfizer Inc Health & Science
From CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Tags Healthy Returns Vertex Pharmaceuticals Inc bluebird bio Inc
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Healthy Returns Social issues Health care industry
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Roche Holding AG Healthy Returns Social issues
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Healthy Returns Social issues Health care industry
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Berkshire Hathaway Inc Health care industry Eli Lilly and Co
From CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
Tags Health & Science Science Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
Tags Sanofi SA Social issues Healthy Returns
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Healthy Returns Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Health care industry Bristol/Myers Squibb Co Breaking News: Politics
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Healthy Returns Zealand Pharma A/S Augmedix Inc
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags AstraZeneca PLC Health care industry Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Novo Nordisk A/S Eli Lilly and Co Health care industry
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Healthy Returns Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Biotech and Pharmaceuticals Health & Science Altimmune Inc
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Altimmune Inc Science Health & Science
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.